Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4

This study has been completed.

First Received: September 20, 1999 Last Updated: August 11, 2008 History of Changes

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) University of Texas
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000307

Purpose

The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.

Condition	Intervention	Phase
Alcohol-Related Disorders Cocaine-Related Disorders	Drug: Naltrexone	Phase II

Study Type:	Interventional
Study Design:	Treatment
Official Title:	Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients

Resource links provided by NLM:

Drug Information available for: Naltrexone Naltrexone hydrochloride

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Verified abstinence from cocaine [ Time Frame: over the 12 weeks of study ] [ Designated as safety issue: No ]

Estimated Enrollment:	0
Study Start Date:	April 2003
Study Completion Date:	April 2007
Primary Completion Date:	April 2007 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	18 Years to 50 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000307

Locations

United States, Texas
University of Texas Health Science Center
Houston, Texas, United States, 77225

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Texas

Investigators

Principal Investigator:

John Grabowski, Ph.D.

University of Texas

More Information

No publications provided

Responsible Party:	University of Texas Medical School at Houston ( Joy Schmitz, Ph.D. )
Study ID Numbers:	NIDA-09262-4, P50-09262-4
Study First Received:	September 20, 1999
Last Updated:	August 11, 2008
ClinicalTrials.gov Identifier:	NCT00000307 History of Changes
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Cocaine-Related Disorders
Mental Disorders
Narcotic Antagonists
Naltrexone
Substance-Related Disorders

Disorders of Environmental Origin
Narcotics
Alcohol-Related Disorders
Peripheral Nervous System Agents
Cocaine

Additional relevant MeSH terms:

Cocaine-Related Disorders
Disease
Narcotic Antagonists
Physiological Effects of Drugs
Disorders of Environmental Origin
Pharmacologic Actions
Pathologic Processes
Mental Disorders

Sensory System Agents
Therapeutic Uses
Naltrexone
Substance-Related Disorders
Alcohol-Related Disorders
Peripheral Nervous System Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on July 02, 2009